SARS-CoV-IN-3 is a potent inhibitor of SARS-CoV replication (EC50 = 3.6 μM in Vero cells); exhibits antiplasmodial activity against P. falciparum 3D7 and W2 strains (IC50 = 11.7 and 20.4 nM, respectively; IC90 = 29.19 and 56 nM, respectively); demonstrates anti-HIV-1 activity by reducing HIV-1-induced cytopathic effects in MT-4 cells (EC50 = 10 μM); and shows superior in vitro antimalarial activity compared to chloroquine.